Valogic Bio, LLC

Valogic Bio, LLC, a Frederick, Maryland-based small disadvantaged business, provides laboratory certification, testing, and compliance services to federal health and research agencies as a prime contractor operating exclusively under full-and-open competition with no set-aside designations across its recent prime footprint.

Valogic Bio specializes in cleanroom certification, biological safety cabinet testing and recertification, HEPA filter maintenance and certification, equipment calibration, environmental monitoring, temperature mapping, air visualization studies, and facility qualification services. These services ensure biomedical research and clinical facilities maintain validated controlled environments meeting FDA, ISO, and United States Pharmacopeia regulatory standards. The company's work footprint spans NAICS 541712 (Testing Laboratories and Services), with the top PSC category as Other Quality Control/Test/Inspect services for instruments and laboratory equipment.

The vendor's customer base is heavily concentrated. The National Institutes of Health Clinical Center accounts for 52 of 69 awards (75% of total awards) and $55.5 million of the $56.1 million combined potential value across the portfolio (99% concentration). The National Cancer Institute contributes 11 awards ($304 thousand combined potential value). The Bureau of Medicine and Surgery, Veterans Health Administration Veterans Integrated Service Network 5, and the U.S. Secret Service each account for one to two awards worth less than $200 thousand combined. The National Institutes of Health Office of Logistics and Acquisition Operations holds one award valued at $50 thousand. This customer concentration—anchored almost entirely on NIH Clinical Center—defines Valogic Bio's federal market position.

Valogic Bio's primary contract vehicle is NIH Clinical Center Indefinite Delivery Contract 75N90021D00025, a five-year, $50 million IDIQ awarded May 17, 2021, and extending through May 16, 2026, for the Aseptic Processing Facility Certification and Testing Program. The company has issued 60 task orders under this vehicle, carrying $5.7 million in combined potential value. Individual delivery orders under the IDIQ have ranged from approximately $890 to $937,160. Beyond the primary IDIQ, Valogic Bio receives individual purchase orders and direct task orders from NCI, Bureau of Medicine and Surgery, and other agencies, typically on full-and-open basis without set-aside designation.

Activity shows decline over the past five years: 20 awards in 2022, declining to 15 in 2023, 12 in 2024, 8 in 2025, and 3 in 2026. Only 2 awards with combined potential value of $146 thousand face ultimate completion in the next twenty-four months, indicating limited near-term recompete exposure and suggesting the underlying NIH Clinical Center IDIQ contract—which completes May 16, 2026—will be the primary recompete opportunity. Service Contract Inventory data show zero SCI-reportable invoiced revenue across FY2022 and FY2024, indicating that Valogic Bio's federal service work either remains below the $150,000 SCI reporting threshold on an individual basis or is classified; SCI does not capture the company's actual federal service delivery.

Valogic Bio operates as a pure prime contractor (100% of awards) with no documented subcontractor engagement in the source award portfolio. The vendor builds its own delivery teams for cleanroom validation, equipment testing, environmental sampling, and facility qualification work rather than relying on subcontractors, positioning it as a direct service provider to NIH facilities in Bethesda, Frederick, and Rockville, Maryland, and NCI locations in Bethesda and Rockville.

Validation Consulting Service